PROQR THERAPEUTICS NV (PRQR)
NL0010872495 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to PRQR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.5. This target is 224.43% above the current price.
PRQR was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PRQR.
In the previous month the buy percentage consensus was at a similar level.
PRQR was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-12 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-29 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2024-05-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-18 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-03-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-08 | Chardan Capital | Upgrade | Neutral -> Buy |
| 2023-11-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-09-18 | Citigroup | Maintains | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-04 | Chardan Capital | Reiterate | Neutral -> Neutral |
| 2023-05-17 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-05-17 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-30 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-23 | Raymond James | Maintains | Outperform |
| 2022-12-22 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-12 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2022-08-12 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2022-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-06 | Chardan Capital | Maintains | Buy |
| 2022-04-14 | Chardan Capital | Maintains | Buy |
| 2022-04-14 | JMP Securities | Maintains | Market Outperform |
| 2022-02-14 | Chardan Capital | Maintains | Buy |